A

Arbutus Biopharma Corp
D

ABUS

3.42500
USD
-0.02
(-0.44%)
مغلق
حجم التداول
48,428
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
649,009,021
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    -0.03500
    (-0.88%)
    3.95000 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Arbutus Biopharma Corp

القطاع: Healthcare
الصناعة: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.